Search

everythinglearnresearchcommunity

for

Search:↓

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Fish oil improves skin health in people with diabetes and high cholesterol.

Oral contraceptives with desogestrel and drospirenone improve PCOS symptoms.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Isotretinoin can safely and effectively control acne with proper risk management and monitoring.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Various treatments exist for hair loss, but more research is needed for better options.

Visceral massage improves skin health and metabolism.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Finasteride effectively treats baldness but may cause sexual side effects.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.